Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals Shares Homepage, Bse Sensex,NSE Nifty,Latest Prices,Live News,Gainers Losersd,Top Performer,Market Commentry,Live Quotes,Bulk Deals
myirislogo
21 November, 2024 18:57 IST
Earnings
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Yes Bank 24.08 42.49
Tata Stl 136.10 30.24
Ong Corp 255.50 95.26
I T C Lt 439.00 28.72
Ntpc Ltd 318.20 88.67
Clear All Clear Last
Equity
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
Market Pulse
Leaders
Laggards
FII Activity
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Quotes
Charts
Financials
Recent News
Broker Research
Research
Research Reports
Bafna Pharmaceuticals Limited
Pharmaceuticals - Bulk Drugs and Formulations
BSE:532989NSE:BAFNAPHBloomberg:BFNA@INReuters:BAFP.BO
Market Lot: 1Face Value: 10ISIN Demat: INE878I01022
QuotesChartsFinancialsResearchRecent News
MF HoldingBSE/NSE Notices
Company Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 11-JAN-24
Closure of Trading Window 29-DEC-23
Discrepancies In Financial Results. 09-DEC-23
Announcement under Regulation 30 (LODR)-Strikes /Lockouts / Disturbances 08-DEC-23
Announcement under Regulation 30 (LODR)-Strikes /Lockouts / Disturbances 07-DEC-23
Announcement under Regulation 30 (LODR)-Newspaper Publication 10-NOV-23
Financial Results For The Quarter And Half Year Ended September 2023. 10-NOV-23
Board Meeting Outcome for Approval Of Un-Audited Financial Results Of The Company For The II Quarter And Half Year Ended September 30, 2023, For The FY 2023-24. 09-NOV-23
Board Meeting Intimation for Intimation Of Meeting Of Board Of Directors - Approval Of Q2 FY24 Financial Results. 30-OCT-23
Submission Of Certificate By RTA In Compliance Of Regulation 74(5) Of SEBI (Depository & Participants) Regulations, 2018, For The Quarter Ended September 30, 2023.\r\n 09-OCT-23
Statement Of Investor Complaints - Quarter Ended September 30, 2023.\r\n\r\n 04-OCT-23
Closure of Trading Window 29-SEP-23

© All rights reserved. IRIS Business Services Limited
Disclaimer